Overcoming the delivery barrier of oligonucleotide drugs and enhancing nucleoside drug efficiency: The use of nucleolipids

X Zhou, S Wang, Y Zhu, Y Pan… - Medicinal Research …, 2020 - Wiley Online Library
With the rapid development of synthetic technology and biological technology, many nucleic
acid‐based drugs have entered the clinical trials. However, their inherent disabilities in …
被引用次数：14 相关文章

Overcoming the delivery barrier of oligonucleotide drugs and enhancing nucleoside drug efficiency: The use of nucleolipids

X Zhou, S Wang, Y Zhu, Y Pan… - Medicinal research …, 2020 - pubmed.ncbi.nlm.nih.gov
With the rapid development of synthetic technology and biological technology, many nucleic
acid-based drugs have entered the clinical trials. However, their inherent disabilities in …

Overcoming the delivery barrier of oligonucleotide drugs and enhancing nucleoside drug efficiency: The use of nucleolipids.

X Zhou, S Wang, Y Zhu, Y Pan, L Zhang… - Medicinal Research …, 2019 - europepmc.org
With the rapid development of synthetic technology and biological technology, many nucleic
acid-based drugs have entered the clinical trials. However, their inherent disabilities in …
[PDF] researchgate.net

[PDF][PDF] Overcoming the delivery barrier of oligonucleotide drugs and enhancing nucleoside drug efficiency: The use of nucleolipids

X Zhou, S Wang, Y Zhu, Y Pan, L Zhang, Z Yang - researchgate.net
With the rapid development of synthetic technology and biological technology, many nucleic
acid‐based drugs have entered the clinical trials. However, their inherent disabilities in …

Overcoming the delivery barrier of oligonucleotide drugs and enhancing nucleoside drug efficiency: The use of nucleolipids.

X Zhou, S Wang, Y Zhu, Y Pan… - Medicinal Research …, 2020 - search.ebscohost.com
With the rapid development of synthetic technology and biological technology, many nucleic
acid‐based drugs have entered the clinical trials. However, their inherent disabilities in …